Page 219 - Read Online

Cardinale et al. Hepatoma Res 2018;4:20 I http://dx.doi.org/10.20517/2394-5079.2018.46 Page 13 of 16

56. Carpino G, Cardinale V, Renzi A, Hov JR, Berloco PB, Rossi M, Karlsen TH, Alvaro D, Gaudio E. Activation of biliary tree stem cells
within peribiliary glands in primary sclerosing cholangitis. J Hepatol 2015;63:1220-8.
57. Huai JP, Ding J, Ye XH, Chen YP. Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of
population-based studies. Asian Pac J Cancer Prev 2014;15:3477-82.
58. Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU,
Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A,
Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN
Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C,
Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg
CP, Manns M, Lindor K4, Hirschfield G5, Hansen BE, Boberg KM; International PSC Study Group. Patient age, sex, and inflammatory
bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 2017;152:1975-84.e8.
59. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-84.
60. Tiwari SK, Khan AA, Ibrahim M, Habeeb MA, Habibullah CM. Helicobacter pylori and other Helicobacter species DNA in human bile
samples from patients with various hepatobiliary diseases. World J Gastroenterol 2006;12:2181-6.
61. Bulajic M, Maisonneuve P, Schneider-Brachert W, Müller P, Reischl U, Stimec B, Lehn N, Lowenfels AB, Löhr M. Helicobacter pylori
and the risk of benign and malignant biliary tract disease. Cancer 2002;95:1946-53.
62. Chang JS, Tsai CR, Chen LT. Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control
study. PLoS One 2013;8:e69981.
63. Pandey M, Shukla M. Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers. Surg Oncol
2009;18:51-6.
64. Murphy G, Michel A, Taylor PR, Albanes D, Weinstein SJ, Virtamo J, Parisi D, Snyder K, Butt J, McGlynn KA, Koshiol J, Pawlita
M, Lai GY, Abnet CC, Dawsey SM, Freedman ND. Association of seropositivity to Helicobacter species and biliary tract cancer in the
ATBC study. Hepatology 2014;60:1963-71.
65. Kaewpitoon SJ, Loyd RA, Rujirakul R, Panpimanmas S, Matrakool L, Tongtawee T, Kootanavanichpong N, Pengsaa P, Kompor
P, Chavengkun W, Kujapun J, Norkaew J, Ponphimai S, Padchasuwan N, Polsripradist P, Eksanti T, Phatisena T, Kaewpitoon N.
Helicobacter species are possible risk factors of cholangiocarcinoma. Asian Pac J Cancer Prev 2016;17:37-44.
66. Leelawat K, Suksumek N, Leelawat S, Lek-Uthai U. Detection of VacA gene specific for Helicobactor pylori in hepatocellular
carcinoma and cholangiocarcinoma specimens of Thai patients. Southeast Asian J Trop Med Public Health 2007;38:881-5.
67. Sithithaworn P, Yongvanit P, Duenngai K, Kiatsopit N, Pairojkul C. Roles of liver fluke infection as risk factor for cholangiocarcinoma.
J Hepatobiliary Pancreat Sci 2014;21:301-8.
68. Xia J, Jiang SC, Peng HJ. Association between liver fluke infection and hepatobiliary pathological changes: a systematic review and
meta-analysis. PLoS One 2015;10:1-19.
69. Li J, Han T, Xu L, Luan X. Diabetes mellitus and the risk of cholangiocarcinoma: an updated meta-analysis. Prz Gastroenterol
2015;10:108-17.
70. Shaib YH, El Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a
case-control study. Gastroenterology 2005;128:620-6.
71. Huang YJ, Wu AT, Chiou YH, Chuang MT, Meng TC, Chien LN, Yen Y. Interactive role of diabetes mellitus and female sex in the risk
of cholangiocarcinoma: a population-based nested case–control study. Oncotarget 2017;8:6642-51.
72. Carpino G, Puca R, Cardinale V Renzi A, Scafetta G, Nevi L, Rossi M, Berloco PB, Ginanni Corradini S, Reid LM, Maroder M, Gaudio
E, Alvaro D. Peribiliary glands as a niche of extrapancreatic precursors yielding insulin-producing cells in experimental and human
diabetes. Stem Cells 2016;34:1332-42.
73. Chaiterakij R, Yang JD, Harmsen WS, Slettedahl SW, Mettler TA, Fredericksen ZS, Kim WR, Gores GJ, Roberts RO, Olson JE,
Therneau TM, Roberts LR. Risk factor for intrahepatic cholangiocarcinoma association between metformin use and reduced cancer risk.
Hepatology 2013;57:648-55.
74. Ling S, Feng T, Ke Q, Fan N, Li L, Li Z, Dong C, Wang C, Xu F, Li Y, Wang L. Metformin inhibits proliferation and enhances
chemosensitivity of intrahepatic cholangiocarcinoma cell lines. Oncol Rep 2014;31:2611-8.
75. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for
intrahepatic cholangiocarcinoma. J Hepatol 2012;57:69-76.
76. Reddy SK, Hyder O, Marsh JW, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Aldrighetti L, Geller
DA, Sempoux C, Herlea V, Popescu I, Anders R, Rubbia-Brandt L, Gigot JF, Mentha G, Pawlik TM. Prevalence of nonalcoholic
steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma. J Gastrointest Surg 2013;17:748-55.
77. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemastu T. Hepatitis B and C virus, Clonorchis sinensis for the
risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996;25:933-40.
78. Li H, Hu B, Zhou ZQ, Guan J, Zhang ZY, Zhou GW. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and
extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies. World J Surg Oncol
2015;13:161-8.
79. Plentz RR, Malek NP. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Pract Res Clin Gastroenterol
2015;29:245-52.
80. Zhou HB, Hu JY, Hu HP. Hepatitis B virus infection and intrahepatic cholangiocarcinoma. World J Gastroenterol 2014;20:5721-9.
81. Zhang H, Biqing Z, He Z, Jianxin L, Wenting Z. HBV infection status and the risk of cholangiocacinoma in Asia: a meta-analysis. Bio